close

Вход

Забыли?

вход по аккаунту

?

Национальная Контактная Точка

код для вставкиСкачать
Национальная Контактная Точка
«Здравоохранение»
Седьмой рамочной программы ЕС
Темы конкурсов, планируемые
для объявления в июле 2008 года
Информационный семинар
«Вопросы участия российских организаций в конкурсах
Седьмой рамочной программы ЕС в области
здравоохранения»
30 мая 2008 года
Внимание!
Все темы конкурсов являются
предварительными и могут
изменяться, в зависимости от
решения Европейской Комиссии и
консультаций со странами-членами
Европейского Союза.
Конкурсы по здравоохранению
1. BIOTECHNOLOGY, GENERIC TOOLS AND MEDICAL
TECHNOLOGIES FOR HUMAN HEALTH
(Биотехнологии, генетические методы и технологии
для здоровья человека)
2. TRANSLATING RESEARCH FOR HUMAN HEALTH
(Трансляционные исследования здоровья человека)
3. OPTIMISING DELIVERY OF HEALTH CARE TO
EUROPEAN CITIZENS
(Оптимизация обеспечения здравоохранения для
европейцев)
4. OTHER ACTIONS ACROSS THE HEALTH THEME
(Другая деятельность, касающаяся здравоохранения)
1.
BIOTECHNOLOGY, GENERIC TOOLS AND
MEDICAL TECHNOLOGIES FOR HUMAN
HEALTH
1.1 HIGH-THROUGHPUT RESEARCH
(Высокопроизводительные методы проведения
исследований)
1.2 DETECTION, DIAGNOSIS AND MONITORING
(Обнаружение, диагностика и мониторинг)
1.3 PREDICTING SUITABILITY, SAFETY AND EFFICACY OF
THERAPIES
(Диагностика соответствия, безопасности и
эффективности лечения)
1.4 INNOVATIVE THERAPEUTIC APPROACHES AND
INTERVENTIONS
(Инновационные терапевтические подходы и
изобретения)
1.1 HIGH-THROUGHPUT RESEARCH
(Высокопроизводительные методы проведения
исследований)
• Computational tools for genome annotation and
genotype/phenotype data integration (Largescale integrating project, max. EUR 12 000 000)
• High throughput tools and technologies to
analyse samples in large-scale human biobanks
(Large-scale integrating project, max. EUR 12
000 000)
• Tools, technologies and resources for the
characterization of protein functions (Largescale integrating project, max. EUR 12 000 000)
1.2 DETECTION, DIAGNOSIS AND
MONITORING
(Обнаружение, диагностика и мониторинг)
• Development of tools for sensitive and specific detection of proteins
and their interactions for diagnostic purposes (Small or mediumscale focused research project, max. EUR 6 000 000)
• Design of methods suited to identify epigenetic factors and their use
in the genetic diagnosis of relevant disorders (Small or mediumscale focused research project, max. EUR 3 000 000)
• Novel MR-compatible PET detectors for simultaneous PET/MRI
imaging (Large-scale integrating project, max. EUR 12 000 000)
• Novel imaging systems for in vivo monitoring and quality control
during tumour ion beam therapy (Small or medium-scale focused
research project, max. EUR 6 000 000)
• Activatable or smart in vivo imaging agents reporting on physicochemical or molecular changes relevant to the diagnosis and/or
monitoring of diseases (Small or medium-scale focused research
project, max. EUR 6 000 000)
• Evaluation of the potential health impact of diagnosis imaging
agents doses (Coordination and Support Action, max. EUR 500 000)
1.3 PREDICTING SUITABILITY, SAFETY AND
EFFICACY OF THERAPIES
(Диагностика соответствия, безопасности и
эффективности лечения)
• New initiatives towards the implementation
of the Replace, Reduce and Refine
strategy (Co-ordination Action)
Develop and implement a co-ordinated
approach towards faster application of
existing safety testing research results in
industry and for regulatory purposes, fully
respecting existing and future animal
protection legislation.
1.4 INNOVATIVE THERAPEUTIC APPROACHES
AND INTERVENTIONS
(Инновационные терапевтические подходы и
изобретения)
• Cell therapy for tissue and organs (Large-scale
integrating project, max. EUR 12 000 000)
• Regeneration of tissue using bio-compatible
materials and cells (Large-scale integrating
project, max. EUR 12 000 000)
• Activation of endogenous cells as an approach
to regenerative medicine (Large-scale
integrating project, max. EUR 12 000 000)
2. TRANSLATING RESEARCH FOR HUMAN
HEALTH
2.1 INTEGRATING BIOLOGICAL DATA AND PROCESSES: LARGESCALE DATA GATHERING, SYSTEMS BIOLOGY
(Интегрированные биологические данные и процессы:
крупномасштабный сбор материала, системная биология)
2.2 RESEARCH ON THE BRAIN AND RELATED DISEASES,
HUMAN DEVELOPMENT AND AGEING
(Исследования мозга и его заболеваний, развитие человека и
старение)
2.3 TRANSLATIONAL RESEARCH IN MAJOR INFECTIOUS
DISEASES: TO CONFRONT MAJOR THREATS TO PUBLIC
HEALTH
(Трансляционные исследования большинства инфекционных
заболеваний: противостояние главным угрозам здоровью
населения)
2.4 TRANSLATIONAL RESEARCH IN OTHER MAJOR DISEASES
(Трансляционные исследования других важных заболеваний)
2.1 INTEGRATING BIOLOGICAL DATA AND
PROCESSES: LARGE-SCALE DATA GATHERING,
SYSTEMS BIOLOGY
2.1.1 Large scale data gathering
• Large-scale functional genomics effort in multicellular organisms to elucidate the function of
human genes products (Large-scale integrating
project, max. EUR 12 000 000)
• Large-scale functional genomics efforts to
identify molecular determinants of cancer
(Large-scale integrating project, max. EUR 12
000 000)
• Characterisation of human genetic variation in
Europe (Large-scale integrating project, max.
EUR 12 000 000)
2.1 INTEGRATING BIOLOGICAL DATA AND
PROCESSES: LARGE-SCALE DATA GATHERING,
SYSTEMS BIOLOGY
2.1.2 Systems biology
(Системная биология)
• Systems biology approaches for basic
biological processes relevant to health and
disease (Large-scale integrating project,
max. EUR 12 000 000)
2.2 RESEARCH ON THE BRAIN AND RELATED
DISEASES, HUMAN DEVELOPMENT AND AGEING
2.2.1 Brain and brain-related diseases
(Болезни мозга и относящиеся к ним заболевания)
• Synaptopathies: genesis, mechanisms and therapy
(Large-scale integrating project, max. EUR 12 000 000)
• Identifying genetic and environmental interactions in
schizophrenia (Large-scale integrating project, max.
EUR 12 000 000)
• Optimising current therapeutic approaches to
schizophrenia (Large-scale integrating project, max.
EUR 12 000 000)
• Understanding the blood brain barrier (BBB) to improve
drug delivery to the brain(Small or medium-scale
focused research project, max. EUR 3 000 000)
• Psycho-social factors of brain disorders (Coordination
Action project, max. EUR 1 500 000)
2.2 RESEARCH ON THE BRAIN AND RELATED
DISEASES, HUMAN DEVELOPMENT AND AGEING
2.2.2. Human development and ageing
(Развитие и старение человека)
Исследования по данной тематике
временно не проводятся
2.3 TRANSLATIONAL RESEARCH IN MAJOR
INFECTIOUS DISEASES: TO CONFRONT MAJOR
THREATS TO PUBLIC HEALTH
2.3.1 Anti-microbial drug resistance including fungal
pathogens
• Global collaborative research on the prevention of
antibiotic resistance (Large-scale integrating project, max. EUR
12 000 000)
• Impact of specific antibiotic therapies on the prevalence
of resistant bacteria in the human host (Small or
medium-scale focused research project, max. EUR 6
000 000)
• Clinical evaluation of point-of-care diagnostic tests for
microbial detection and identification, antibiotic
susceptibility determination and biomarkers (Small or
medium-scale focused research project, max. EUR 6
000 000)
2.3 TRANSLATIONAL RESEARCH IN MAJOR
INFECTIOUS DISEASES: TO CONFRONT MAJOR
THREATS TO PUBLIC HEALTH
2.3.2 HIV/AIDS, malaria and tuberculosis
(ВИЧ/СПИД, малярия, туберкулез)
• Integration of European efforts in research on malaria (Network of
Excellence projects, max. EUR 12 000 000)
• Identification and pre-clinical testing of new vaccine candidates for
tuberculosis (Large-scale integrating project, max. EUR 12 000 000)
• Discovery and/or development of new and promising anti-HIV
microbicides (Large-scale integrating project, max. EUR 12 000 000)
• Mucosal and tropical vaccines for poverty related diseases
(HIV/AIDS, malaria and/or TB) (Large-scale integrating project, max.
EUR 12 000 000)
• Translational vaccine research for poverty related diseases
(HIV/AIDS, malaria and/or TB) (Small or medium-scale focused
research project, max. EUR 6 000 000)
• ERA-NET for stepping up European cooperation in HIV/AIDS
research (ERA-NET Coordination Action Projects, max. EUR 2 000
000)
2.3 TRANSLATIONAL RESEARCH IN MAJOR
INFECTIOUS DISEASES: TO CONFRONT MAJOR
THREATS TO PUBLIC HEALTH
2.3.3 Potentially new and re-emerging
epidemics
(Потенциально новые или вновь возникающие
эпидемии)
- Efficacy and effectiveness of personal
protection equipment and other measures
against influenza transmission (Small or
medium-scale focused research project,
max. EUR 3 000 000)
2.3 TRANSLATIONAL RESEARCH IN MAJOR
INFECTIOUS DISEASES: TO CONFRONT MAJOR
THREATS TO PUBLIC HEALTH
2.3.4 Neglected infectious diseases
(Малоизученные инфекционные заболевания)
• Discovery and development of new vaccines or drugs for
helminth infections(Small or medium-scale focused
research project, max. EUR 6 000 000)
• Identification and development of vaccine candidates for
neglected bacterial infections (Small or medium-scale
focused research project, max. EUR 6 000 000)
• Human Immune Responses to co-infections of povertyrelated (HIV/AIDS, malaria, TB) and neglected
infectious diseases SICA (Large-scale integrating
project, max. EUR 12 000 000)
2.4 TRANSLATIONAL RESEARCH IN
OTHER MAJOR DISEASES
2.4.1 Cancer (Рак)
Исследования по данной тематике
временно не проводятся
2.4 TRANSLATIONAL RESEARCH IN
OTHER MAJOR DISEASES
2.4.2 Cardiovascular disease (Сердечнососудистые заболевания)
• Improved or new therapeutic approaches for the
treatment of heart failure (Large-scale
integrating project, max. EUR 12 000 000)
• Cardiac arrhythmias: from genes to improved
management of patients (Large-scale integrating
project, max. EUR 12 000 000)
• Translation of basic knowledge on inherited
cardiomyopathies into clinical practice (Small or
medium-scale focused research project, max.
EUR 3 000 000)
2.4 TRANSLATIONAL RESEARCH IN
OTHER MAJOR DISEASES
2.4.3 Diabetes and obesity
(Диабет и ожирение)
• Novel therapeutic approach to pregnancyincluded diabetes (Small or medium-scale
focused research project, max. EUR 3 000 000)
• Novel immunotherapies for type 1 diabetes
(Large-scale integrating project, max. EUR 12
000 000)
• Molecular pathways in food intake at CNS-livergut regulation level (Small or medium-scale
focused research project, max. EUR 3 000 000)
2.4 TRANSLATIONAL RESEARCH IN
OTHER MAJOR DISEASES
2.4.4 Rare diseases
(Редкие заболевания)
• Rare neurological diseases (Small or
medium-scale focused research project,
max. EUR 6 000 000)
• Preclinical development of substances
with clear potential as orphan drugs (Small
or medium-scale focused research project,
max. EUR 3 000 000)
2.4 TRANSLATIONAL RESEARCH IN
OTHER MAJOR DISEASES
2.4.5 Other chronic diseases
(Другие хронические заболевания)
• Prevention and treatment of non-alcoholic fatty
liver disease (NAFDL) (Small or medium-scale
focused research project, max. EUR 6 000 000)
• Role of inflammation in the development of
chronic kidney disease (CKD) (Small or mediumscale focused research project, max. EUR 6 000
000)
3. OPTIMISING DELIVERY OF HEALTH CARE
TO EUROPEAN CITIZENS
3.1 TRANSLATING THE RESULTS OF CLINICAL RESEARCH OUTCOME
INTO CLINICAL PRACTICE INCLUDING BETTER USE OF MEDICINES,
AND APPROPRIATE USE OF BEHAVIOURAL AND ORGANISATIONAL
INTERVENTIONS AND NEW HEALTH THERAPIES AND
TECHNOLOGIES
(Внедрение клинических исследований в клиническую практику)
3.2 QUALITY, EFFICIENCY AND SOLIDARITY OF HEALTH CARE
SYSTEMS INCLUDING TRANSITIONAL HEALTH SYSTEMS
(Качество и единство систем здравоохранения)
3.3 ENHANCED HEALTH PROMOTION AND DISEASE PREVENTION
(Профилактика и предупреждение заболеваний)
3.4 HORIZONTAL COORDINATION AND SUPPORT ACTIONS ACROSS
"OPTIMISING THE DELIVERY OF HEALTH CARE TO EUROPEAN
CITIZENS"
(Горизонтальная координация и поддержка деятельности по
«Оптимизации обеспечения здравоохранения для европейцев»)
3.5 SPECIFIC INTERNATIONAL COOPERATION ACTIONS FOR HEALTH
SYSTEM RESEARCH
(Специальные совместные действия международного
сотрудничества по системным медицинским исследованиям)
3.1 TRANSLATING THE RESULTS OF CLINICAL RESEARCH
OUTCOME INTO CLINICAL PRACTICE INCLUDING BETTER USE
OF MEDICINES, AND APPROPRIATE USE OF BEHAVIOURAL AND
ORGANISATIONAL INTERVENTIONS AND NEW HEALTH
THERAPIES AND TECHNOLOGIES
• Patient Safety: Effective implementation of
prevention strategies for healthcare associated
infections (Small or medium-scale focused
research project, max. EUR 3 000 000)
• Improve quality and safety of hospital care
(Small or medium-scale focused research
project, max. EUR 3 000 000)
• Complementary and alternative Medicine
• Improved treatment of chronic diseases in
developing countries (Small or medium-scale
focused research project, max. EUR 3 000 000)
3.2 QUALITY, EFFICIENCY AND SOLIDARITY
OF HEALTH CARE SYSTEMS INCLUDING
TRANSITIONAL HEALTH SYSTEMS
• Organisation of dementia care(Small or medium-scale
focused research project, max. EUR 3 000 000)
• Health care outcomes and cost-benefits (Small or mediumscale focused research project, max. EUR 3 000 000)
• Primary care quality linkage to costs (Small or medium-scale
focused research project, max. EUR 3 000 000)
• Impact of cross border collaboration on health services (Small
or medium-scale focused research project, max. EUR 6 000
000)
• Research access to comparable health care data
(Coordination Action project, max. EUR 1 500 000)
• Scoping study to address the methodological challenges of
quantifying the socio-economic burden of brain diseases
compared to other major diseases (Coordination and Support
Action, max. EUR 500 000)
3.3 ENHANCED HEALTH PROMOTION AND
DISEASE PREVENTION
• Child and adolescent mental health (Small or mediumscale focused research project, max. EUR 3 000 000)
• Environmental prevention of substance abuse by
adolescents (Small or medium-scale focused research
project, max. EUR 3 000 000)
• Ageing cohorts (Large-scale integrating project, max.
EUR 12 000 000)
• Birth/Mother-Child Cohorts co-ordination (Coordination
Action project, max. EUR 1 500 000)
• European child health research platform (Coordination
Action project, max. EUR 1 500 000)
3.4 HORIZONTAL COORDINATION AND SUPPORT
ACTIONS ACROSS "OPTIMISING THE DELIVERY OF
HEALTH CARE TO EUROPEAN CITIZENS"
Временное прекращение проведения
мероприятий
3.5 SPECIFIC INTERNATIONAL COOPERATION
ACTIONS FOR HEALTH SYSTEM RESEARCH
• Strategies and interventions for improving
reproductive health (Small or medium-scale
focused research project, max. EUR 3 000 000)
• Access to medicines (Small or medium-scale
focused research project, max. EUR 3 000 000)
• Integration of Disease Surveillance and Health
Systems Response (Small or medium-scale
focused research project, max. EUR 6 000 000)
4. OTHER ACTIONS ACROSS THE HEALTH
THEME
4.1 COORDINATION AND SUPPORT
ACTIONS ACROSS THE THEME
(Координационная поддержка
деятельности по теме)
4.2 RESPONDING TO EU POLICY NEEDS
(Ответ на потребности политики
ЕС)
4.1 COORDINATION AND SUPPORT ACTIONS ACROSS
THE THEME
(Координационная поддержка деятельности по
теме)
• Monitoring tool and technology transfer analysis
for Health theme grants during FP7
(Coordination and Support Action project)
• Dissemination of results from research in Life
Sciences and Biotechnology for Health to the
general public and/or information multipliers
(Coordination and Support Action project)
• Targeting Publication Bias (Support Action
project, max. EUR 500 000)
4.2 RESPONDING TO EU POLICY NEEDS
• Adapting off-patent medicines to the specific
needs of paediatric populations (Small or
medium-scale focused research project, max.
EUR 6 000 000)
• Drug Safety Research (Network of Excellence
projects, max. EUR 5 000 000)
• Human Pappilomavirus Vaccination (HPV) and
cervical cancer screening programmes: estimate
of impact of different policy options by way of
desease modeling and health economics (Small
or medium-scale focused research project, max.
EUR 3 000 000)
Рабочая программа
Обращайте внимание на описание
конкурса, содержащееся в Рабочей
программе!
Рабочая программа 2009 по
здравоохранению будет опубликована
вместе с конкурсами, ориентировочно в
июле 2008 года
СПАСИБО ЗА ВНИМАНИЕ!
Документ
Категория
Презентации
Просмотров
1
Размер файла
176 Кб
Теги
1/--страниц
Пожаловаться на содержимое документа